We are driven by a steadfast commitment to pushing the boundaries in Diagnostic Cardiology and seizing innovation opportunities in healthcare service models.
Our mission is to transform healthcare by leveraging technology and breaking down barriers to make a tangible difference in patient care and advance the field of Diagnostic Cardiology.
With a legacy spanning over five decades, we have consistently been at the forefront of medical technology, delivering state-of-the-art solutions for diagnosing and monitoring cardiac conditions.
Today, we are taking yet another significant step forward by introducing an Open Diagnostic Cardiology Ecosystem, empowering cardiologists and healthcare professionals to work smarter and more efficiently, ultimately improving patient care.
Within this ecosystem, we seamlessly integrate differentiated devices and a cloud-based data management Web Application (WebApp). This integration is designed to streamline data management, optimize workflow efficiencies to deliver a cybersecure solution available anywhere, anytime.
The goal is to provide a comprehensive interconnected Ecosystem that delivers a Leading Diagnostic Cardiology solution encompassing a Patient-centric remote Engagement platform.
Quality management system for medical devices
ISO 9001: 2015
Quality Management Systems
Normative Update in progress
ISO/IEC 27001: 2013
Information Security Management Systems
Council Directive 93/42/ECC
Medical Devices and Accessories Directive
Headquartered in Trento, Italy, Cardioline’s influence extends well beyond Italy, with a strong presence in over 100 countries.
We collaborate with a vast network of distributors, healthcare institutions, and clinicians to make our technology accessible worldwide.
Our commitment to expanding access to high-quality cardiovascular diagnostics has made us a trusted partner in the global healthcare community.
Founded in 1962, Cardioline has evolved into a global leader in the design, manufacturing, and distribution of electrocardiography (ECG) devices and other cardiovascular diagnostic equipment, boasting a rich history of pioneering advancements that have revolutionized the healthcare industry.
Cardioline releases a Telemedicine solution encompassing a full engagement platform including multi-modalities beyond Diagnostic Cardiology.
Cardioline launches 3 channel Holter Patch recorder.
Cardioline is Acquired by Archimed, a global leader in Healthcare investment, the Cardioline Leadership team remain in situ.
Launch of extended functionality for remote recording and reporting in Diagnostic Cardiology.
CubeStress, a new stress exercise platform is released to the market.
CubeHolter, the world’s first web-based Holter platform is developed. Cardioline inaugurates its first foreign production line in Sao Paulo, Brazil.
Release of Cardioline ECG WebApp, a revolutionary multimodality ECG management system based on the Web, providing easy access from anywhere, inside or outside the health organization (ambulances, primary care centers).
Release of TouchECG digital ECG using Bluetooth data transmission for “Windows” and “Android” platforms.
Release of high connectivity ECG series + and S line electrocardiographs.
Operating control is taken over by Cardioline S.p.A with plans to maintain and strengthen the historic brand and the desire to transform new innovations into the product portfolio.
Elettronica Trentina is born and enters the market with the first Cardioline branded electrocardiograph. Over 400,000 devices have been sold in more than 60 countries, making the Cardioline brand famous in Italy and worldwide.